PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
02-Apr-2020 PCR Biosystems continues to scale up operations to ensure ongoing availability of COVID-19 test reagents PCR Biosystems
01-Apr-2020 Kiniksa Announces Early Evidence of Treatment Response with Mavrilimumab in 6 Patients with Severe COVID-19 Pneumonia and Hyperinflammation Kiniksa
01-Apr-2020 GILEAD SCIENCES ANNOUNCES TWO PHASE 3 RANDOMISED STUDIES TO EVALUATE THE SAFETY AND ANTIVIRAL ACTIVITY OF REMDESIVIR (GS-5734™) IN PARTICIPANTS WITH MODERATE TO SEVERE COVID-19 Gilead
31-Mar-2020 Accord donates two million tablets of hydroxychloroquine to largest COVID-19 trial in the world involving 40,000 frontline healthcare workers Accord Healthcare
25-Mar-2020 1 week to go to SMi’s 22nd Annual Superbugs & Superdrugs Conference  SMi Group
25-Mar-2020 Food Enzymes market is growing worldwide with the key market players such as Specialty Enzymes and Biotechnologies, Biosun, DSM, DuPont, Novozymes, AB Enzymes, Nutriteck, and many more Ricerca Alfa
24-Mar-2020 BellaSeno and Charite – Universitaetsmedizin Berlin Collaborate Under BMBF-Funded SyMBoD Consortium Bella Seno GmbH
24-Mar-2020 Cataract Devices market is flourishing around the globe though the key market players such as Abbott, Bausch & Lomb, Novartis, STAAR Surgical Company, Carl Zeiss AG, and Topcon Corporation among others Ricerca Alfa
23-Mar-2020 Lonza Launches New TheraPEAK™ SfAAV™ Medium to Boost and Optimize the Production of AAV in Sf9 Insect Cells Lonza
20-Mar-2020 EUSA Pharma and the Papa Giovanni XXIII Hospital, Bergamo, Italy announce initiation of an observational case-control study of siltuximab in patients with COVID-19 who have developed serious respiratory complications EUSA Pharma
20-Mar-2020 Impact BioMedical compounds Linebacker and Equivir shown to inhibit SARS-CoV-2 Impact BioMedical
10-Mar-2020 PharmiWeb Launches New Job Board for Pharma & Life Sciences in Australasia PharmiWeb
10-Mar-2020 Positive results from Phase IIb field study of FLU-v vaccine (FLU-v 003), which has been developed by Imutex Limited, hVIVO's 49% joint venture with the SEEK Group. FLU-v is a first-in-class ‘universal’, broad spectrum, standalone, influenza vaccine candidate and the results have now been published in a peer review journal Open Orphan plc
10-Mar-2020 Immutep receives second IND approval for Efti from US FDA Immutep Limited
06-Mar-2020 Hospital PUC-Campinas Celso Pierro joins Patient Network Explorer, expanding Clinerion’s existing patient coverage in Brazil. Clinerion Ltd.
05-Mar-2020 Beijing University of Chinese Medicine collaborates with Elsevier to launch first branch of traditional Chinese medicine taxonomy Elsevier
04-Mar-2020 Cytel champions precision oncology master protocol trial designs Cytel
02-Mar-2020 New Advanced Liquid Chromatography System Delivers Productivity, Precision and Compliance in Routine Analyses Thermo Fisher Scientific
02-Mar-2020 Solentim names Mark Truesdale as new CEO Solentim
28-Feb-2020 Clinerion and iClusion partner to boost the identification and recruitment of more patients into clinical trials. Clinerion Ltd